The two legitimate paths
BPC-157 reaches patients through one of two legitimate routes: a 503A compounding pharmacy fills a prescription from a licensed clinician for a specific patient, or it is provided as part of an IRB-approved clinical research protocol. Both are legal.
The gray-zone path
'Research-grade' BPC-157 sold online without prescription is marketed under 'for research use only' disclaimers. Possession for personal use sits in a regulatory gray zone. Sale and self-administration as a medical treatment is not legal under FDA regulation, although enforcement against individual buyers is uncommon. The bigger problem with this path is sterility, dose accuracy, and the lack of medical supervision.
Sourcing comparison
| Legal status | Sterility | Dosing accuracy | Supervision | |
|---|---|---|---|---|
| 503A compounded prescription | Legal | USP <797> standards | Verified | Licensed clinician |
| Research-grade online | Gray zone | Variable / undocumented | Often inaccurate | None |
| IRB clinical trial | Legal | GMP | Verified | Investigator + IRB |